Suchergebnisse - (Person:"Bafadhel, Mona")

PubPharm (52)

1

Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease : A Biologics Outlook

enthalten in: American journal of respiratory and critical care medicine | 2023

von Rabe, K. | Rennard, S. | Martinez, F. | +10

2

Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 : A Randomized Platform Trial

enthalten in: Annals of internal medicine | 2023

von Reis, G. | Dos Santos Moreira Silva, E. | Medeiros Silva, D. | +133

3

Evaluation of data processing pipelines on real-world electronic health records data for the purpose of measuring patient similarity

enthalten in: PloS one | 2023

von Pikoula, M. | Kallis, C. | Madjiheurem, S. | +3

4

Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids : a mechanistic analysis

enthalten in: The Lancet. Respiratory medicine | 2022

von Baker, J. | Mahdi, M. | Nicolau, D. | +7

CommentIn: Lancet Respir Med. 2022 Jun;10(6):526-527. - PMID 35397799

5

Heterogeneity of IPF exacerbations

enthalten in: The Lancet. Respiratory medicine | 2022

von Ramakrishnan, S. | Bafadhel, M.

CommentOn: Lancet Respir Med. 2022 Jan;10(1):26-34. - PMID 34506761

6

A Comprehensive Analysis of the Stability of Blood Eosinophil Levels

enthalten in: Annals of the American Thoracic Society | 2021

von Chipps, B. | Jarjour, N. | Calhoun, W. | +7

7

Improved COVID-19 outcomes in a large non-invasive respiratory support cohort despite emergence of the alpha variant

enthalten in: BMJ open respiratory research | 2021

von Turnbull, C. | Porter, B. | Evans, S. | +40

8

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE) : a randomised, controlled, open-label, adaptive platform trial

enthalten in: Lancet (London, England) | 2021

von Yu, L. | Bafadhel, M. | Dorward, J. | +50

CommentIn: Lancet. 2021 Sep 4;398(10303):818-819. - PMID 34388397

9

A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial

enthalten in: The European respiratory journal | 2021

von Bafadhel, M. | Barnes, N. | Bourke, S. | +15

10

Research priorities for exacerbations of COPD

enthalten in: The Lancet. Respiratory medicine | 2021

von Alqahtani, J. | Aquilina, J. | Bafadhel, M. | +12

1
2
3
4
5
6
Nächster »
[6]